ANI Pharmaceuticals | ANIP - Trade Debtors


ANI Pharmaceuticals reported $281.08M in Trade Debtors for its fiscal quarter ending in December of 2025.





Trade Debtors Change Date
AbbVie USD 12.77B 132M Sep/2025
ANI Pharmaceuticals USD 281.08M 28.46M Dec/2025
Assertio Holdings USD 39.91M 2.7M Jun/2024
Aurora Cannabis CAD 46.73M 7.59M Sep/2025
Canopy Growth CAD 26.86M 23.17M Sep/2025
Eli Lilly USD 19.46B 2.25B Sep/2025
Emergent BioSolutions USD 290.1M 134.2M Jun/2023
Heron Therapeutics USD 89.59M 8.54M Dec/2025
Hikma Pharmaceutical USD 1.08B 27M Dec/2025
Knight Therapeutics CAD 175.54M 17.32M Sep/2025
Nektar Therapeutics USD 0 2.9M Sep/2024
Novartis USD 8.98B 192M Sep/2025
Omeros USD 8.08M 440K Jun/2024
Perrigo USD 612.8M 31.6M Dec/2025
Sun Pharmaceuticals INR 157.04B 26.1B Sep/2025
Teva Pharmaceutical Industries USD 3.71B 101M Dec/2025